-
2024-515127-11-00
4
2023-12-21
hepatocellular carcinoma
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2023-504602-11-00
5
2023-10-25
Mild to moderate Alzheimer's disease
-
2022-503133-54-00
7
2023-08-09
Solid Tumors
-
2024-512320-11-00
5
2023-08-09
Primary diffuse large B-cell lymphoma of the central nervous system
(P
-
2024-517966-40-00
4
2023-07-13
Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::ABL1 positive (Ph
-
2022-501187-18-00
5
2023-04-24
a. Diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS)
-
2024-515924-35-00
6
2023-01-16
New-Onset Post-Operative Atrial Fibrillation after CABG
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2022-500764-35-00
6
2022-10-13
Patients with advanced HER2-negative, hormone receptor positive (HER2n
-
2024-515290-98-00
4
2022-09-23
Congenital Hyperinsulinism (CHI)
-
2023-504660-41-00
4
2022-07-11
Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (PBC
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2024-516504-42-00
5
2022-03-05
Respiratory distress syndrome in preterm infants
-
2024-510690-16-00
5
2022-01-31
Relapsed/refractory follicular lymphoma
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-512174-10-00
5
2021-11-11
metastatic colorectal cancer
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-513723-16-00
4
2021-10-21
metastatic colorectal cancer
-
2024-514548-10-01
3
2021-07-26
Mild to moderate atopic dermatitis
-
2024-515229-26-00
5
2021-05-21
eosinophilic esophagitis
-
2024-517300-10-01
5
2020-12-17
Resectable diffuse type gastric and gastroesophageal junction Typ II/I
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-518077-34-00
5
2020-09-30
locally advanced rectal cancer